Allied Biotech Corporation announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 334.882 million compared to TWD 365.840 million a year ago. Operating income was TWD 57.507 million compared to TWD 82.482 million a year ago. Net income was TWD 42.152 million compared to TWD 84.034 million a year ago. Basic earnings per share was TWD 0.44 compared to TWD 0.89 a year ago. Diluted earnings per share was TWD 0.44 compared to TWD 0.88 a year ago.